Global Compression Therapy Market Assessment & Opportunity Forecast till 2032

According to a new report published by K D Market Insights, titled, “Compression Therapy Market Insights, Trends, Opportunity Forecast, 2023–2032,” the global compression therapy market size is anticipated to witness moderate growth during the forecast period i.e., 2023-2032. The increasing prevalence of chronic venous diseases, such as deep vein thrombosis (DVT) and lymphedema, which require effective treatment options. Additionally, the aging population and the rising incidence of obesity are the major factors augmenting the growth of the global compression therapy market.

Factors such as the increasing prevalence of chronic venous diseases, such as deep vein thrombosis (DVT), venous leg ulcers, and lymphedema, creates a significant demand for effective treatment options. Compression therapy has proven to be a reliable and non-invasive approach for managing these conditions, are further expected to create ample growth opportunities for the global compression therapy market during the forecast period i.e., 2023-2032. Moreover, the growing incidence of road accidents and sports-related injuries often result in skeletal system injuries, where compression therapy is used to support the healing process and promote faster patient recovery are expected to contribute towards the market growth during the period.

The North America region accounted for the largest share in the global compression therapy market in 2022. The region is further projected to continue dominating in the market during the forecast period. Primarily driven by the United States. The region's high prevalence of chronic venous diseases, well-established healthcare infrastructure, and favorable reimbursement policies contribute to its market dominance.

According to product type, the compression bandages segment accounted for the largest market share in the compression therapy market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.

The global compression therapy market is segmented into product type, technique, application, end user and region. Based on product type, the market is bifurcated into compression garments, compression bandages, compression stockings, compression pumps. Based on technique, it is classified into static compression therapy, dynamic compression therapy. Based on application, it is classified into venous leg ulcers, deep vein thrombosis (DVT), lymphedema, varicose veins, leg ulcer treatment. Based on end user, it is classified into pharmacies retailers, hospitals clinics, e-commerce platforms, home care settings.

The global compression therapy market is analyzed across North America (U.S. Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America) and Middle East Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East Africa).

Key Insights of Neurotrophins Market

On the basis of product type, the compression bandages segment accounted for the largest market share in the compression therapy market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.
On the basis of region, North America accounted for the largest share in the global compression therapy market in 2022. The region is further projected to continue dominating in the market during the forecast period.
On the basis of region, Asia Pacific is estimated to account for the second largest share in the market during the forecast period.
Some of the major compression therapy companies profiled in the report include DJO Global, Inc., BSN medical, medi GmbH Co. KG, Tactile Medical, SIGVARIS, Sanyleg S.r.l., 3M Company, ConvaTec Inc., ArjoHuntleigh (Getinge Group), and Julius Zorn GmbH.